首页|期刊导航|中药药理与临床|加味柴芍六君方抑制IL-8介导的胃癌上皮间质转化的机制研究

加味柴芍六君方抑制IL-8介导的胃癌上皮间质转化的机制研究OA

Mechanism of Modified Chaishao Liujun Prescription in Inhibiting IL8-Mediated Epithelial-Mesenchymal Transition in Gastric Cancer

中文摘要英文摘要

目的:本研究旨在探讨加味柴芍六君方对胃癌上皮间质转化(EMT)过程中白细胞介素-8(IL-8)的调节机制,为胃癌治疗提供新的策略.方法:通过 MTT 法检测加味柴芍六君方对人胃黏膜细胞(GES-1)的毒性及对胃癌细胞(HCG-27)增殖的影响;通过划痕试验和 Transwell 侵袭试验评估该方对细胞迁移和侵袭能力的抑制作用;利用 TGF-β1 10 μg/L 诱导 EMT 模型,并通过慢病毒转染构建 IL-8 过表达细胞模型;采用 ELISA 检测癌胚抗原(CEA)、胃泌素(G-17)和 IL-8 含量,qRT-PCR 和 Western blot 法检测 EMT 标志物(Ecadherin、Ncadherin、Vim-entin、Twist、Snail)及 Il8 的 mRNA 和蛋白表达;免疫荧光法观察 IL-8 蛋白定位.结果:相较于空白对照组,加味柴芍六君方 400 μg/mL 组 HCG-27 细胞的增殖、迁移和侵袭降低(P<0.01),TGF-β1 组、IL-8 组,加味柴芍六君方200、400 μg/mL 组细胞 CEA、G-17 和 IL-8 含量显著升高(P<0.01),过表达 IL-8 组细胞 CEA、G-17、IL-8 含量显著升高(P<0.01).与过表达IL-8 模型对照组比较,加味柴芍六君方200、400 μg/mL 组CEA、G-17 和IL-8 的含量明显降低(P<0.05 或 P<0.01);加味柴芍六君方400 μg/mL+过表达组 Ncadherin、Vimentin、Twist、Snail、IL-8 蛋白和mRNA 表达下调,Ecadherin 上调(P<0.05 或 P<0.01);TGF-β1 组细胞 Twist mRNA 表达上调,Il8、Ecadherin mR-NA 表达下调(P<0.05 或 P<0.01).与 TGF-β1 组比较,加味柴芍六君方+TGF-β1 组细胞 Vimentin、Twist、Snail mRNA 表达下调,Ecadherin、Il8 mRNA 表达上调(P<0.05 或 P<0.01).免疫荧光结果表明,相较于空白对照组,过表达 IL-8 组和 TGF-β1 组的荧光强度较大,而加味柴芍六君方组减弱细胞 IL-8 的荧光强度.结论:加味柴芍六君方通过调控 IL-8 及其下游信号通路,显著抑制了胃癌细胞的 EMT 过程.

Objective:To investigate the regulatory mechanism of modified Chaishao Liujun Prescription(柴芍六君方)on interleukin-8(IL-8)during epithelial-mesenchymal transition(EMT)in gastric cancer,and to provide new strat-egies for its treatment.Methods:The cytotoxicity of modified Chaishao Liujun Prescription on human gastric mucosal cells(GES-1)and its effects on the proliferation of gastric cancer cells(HCG-27)were detected by MTT assay.Scratch wound healing and Transwell invasion assays were used to evaluate its inhibitory effects on cell migration and invasion.An EMT model was induced by TGF-β1(10 μg/L),and an IL-8 overexpression model was constructed by lentiviral transfection.ELISA was used to measure the secretion levels of carcinoembryonic antigen(CEA),gastrin-17(G-17),and IL-8.The proteins and mRNA expression changes of EMT markers(E-cadherin,N-cadherin,Vimentin,Twist,Snail)and IL-8 were analyzed by Western blot and qRT-PCR.Immunofluorescence was used to observe the localization of IL-8 protein.Results:Compared with the blank control group,modified Chaishao Liujun Prescription(400 μg/mL)grop sig-nificantly inhibited the proliferation,migration,and invasion(P<0.01)of HCG-27 cells,the TGF-β1 group,the IL-8 group,and modified Chaishao Liujun Prescription(200,400 μg/mL)groups exhibited significantly elevated levels of CEA,G-17,and IL-8(P<0.01)of cells,and the IL-8 overexpression group exhibited significantly elevated levels of CEA,G-17,and IL-8(P<0.01)of cells.Compared with the IL-8 overexpression model control group,modified Chaishao Liujun Prescription(200,400 μg/mL)groups exhibited significantly reduced levels of CEA,G-17,and IL-8(P<0.05 or P<0.01)of cells,modified Chaishao Liujun Prescription(400 μg/mL)+overexpression group exhibited significantly downregulated the protein and mRNA expression of N-cadherin,Vimentin,Twist,Snail,and IL-8,while up-regulating E-cadherin(P<0.05 or P<0.01)of cells,and the TGF-β1 group showed upregulated the mRNA expression of Twist,while downregulating Il8,Ecadherin(P<0.05 or P<0.01)of cells.Compared with the TGF-β1 group,modi-fied Chaishao Liujun Prescription+TGF-β1 group showed downregulated the mRNA expression of Vimentin,Twist,and Snail,while upregulating E-cadherin and IL-8(P<0.05 or P<0.01)of cells.Immunofluorescence results indicated that,compared with the blank control group,the IL-8 overexpression group and the TGF-β1 group showed stronger fluores-cence intensity,whereas the modified Chaishao Liujun Prescription group attenuated IL-8 fluorescence signal of cells.Conclusion:By regulating IL-8 and its downstream signaling pathways,the modified Chaishao Liujun Prescription signif-icantly inhibited EMT in gastric cancer cells.

蒋敏玲;文辉;何武;杨键

桂林医科大学第一附属医院,桂林 541001桂林医科大学第一附属医院,桂林 541001桂林医科大学第一附属医院,桂林 541001桂林医科大学第一附属医院,桂林 541001

加味柴芍六君方胃癌上皮间质转化白介素8

Modified Chaishao Liujun PrescriptionGastric cancerEpithelial-mesenchymal transitionIL-8

《中药药理与临床》 2026 (6)

2-10,9

广西中医药管理局自筹经费科研课题(编号:GXZYZ20210091).

评论